Akari Therapeutics (AKTX) Other Working Capital Changes (2015 - 2026)

Akari Therapeutics has disclosed Other Working Capital Changes across 5 years of filings, most recently posting $6891.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $6891.0, up 108.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $6891.0 (up 102.5% YoY), and the FY2025 annual result was -$594000.0, down 181.34% from the prior year.
• Other Working Capital Changes came in at $6891.0 for Q1 2026 at Akari Therapeutics, up from -$202000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $59.0 million in Q4 2023 to a low of -$202000.0 in Q4 2024.
• The 4-year median for Other Working Capital Changes is $63573.5 (2025), against an average of $15.2 million.
• Across the five-year window, Other Working Capital Changes sank 100.73% in 2025 and surged 108.2% in 2026, its largest moves.
• Akari Therapeutics' Other Working Capital Changes stood at $59.0 million in 2023, then tumbled by 100.34% to -$202000.0 in 2024, then changed by 0.0% to -$202000.0 in 2025, then soared by 103.41% to $6891.0 in 2026.
• The last three Other Working Capital Changes figures came in at $6891.0 (Q1 2026), -$202000.0 (Q4 2025), and $120256.0 (Q3 2025), per Business Quant data.